ArticleActa pharmacologica Sinica2025

Selumetinib promotes coronary collateral circulation by inducing M2-like macrophage polarization following myocardial infarction.

Ke-Chuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.